We are developing and advancing novel platform technologies to usher in a new era of immunotherapy
At BioNTech, we apply our deep expertise in immunology, drug discovery and fundamental research to develop and advance a toolbox of groundbreaking technologies spanning four drug classes to provide novel treatments and vaccines for people around the world to improve global health.
With a deep understanding of the underlying science, and based on nearly two decades of groundbreaking research, mRNA therapeutics are our most advanced assets. In addition, we use the specific properties of cell therapies, antibodies and small molecules, or even synergistic combinations of those different drug classes, to address the treatment challenges for a range of cancer and infectious disease indications.
Broadening the treatment universe
We are continuously building out our platforms and approaches aiming to harness the full power of the immune system and provide better medicines for patients worldwide.